Combination treatment may help cut lifelong ibrutinib for chronic lymphocytic leukemia patients

Published Date: 07 Nov 2025

Chronic lymphocytic leukemia (CLL) is the most prevalent adult leukemia in the Western Hemisphere, affecting approximately 200,000 people in the United States.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Combination treatment may help cut lifelong ibrutinib for chronic lymphocytic leukemia patients

2.

Q&A: Why adolescents and young adults with cancer are falling behind

3.

FINAL USPSTF RECOMMENDATIONS ON ANXIETY, DEPRESSION, AND SUIICIDAL RISK.

4.

Even after a partial ban, asbestos is still used and is a deadly carcinogen, according to the EPA.

5.

Measurable Residual Disease Predicts Real-World AML Relapse


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot